Baker Bros. Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-310,354
| Closed | -$5.91M | – | 113 |
|
|
2018
Q2 | $5.91M | Sell |
310,354
-290,000
| -48% | -$5.52M | 0.04% | 67 |
|
|
2018
Q1 | $10.1M | Buy |
600,354
+176,470
| +42% | +$2.97M | 0.09% | 58 |
|
|
2017
Q4 | $6.44M | Hold |
423,884
| – | – | 0.06% | 70 |
|
|
2017
Q3 | $7.59M | Buy |
+423,884
| New | +$7.59M | 0.06% | 64 |
|
|
2015
Q3 | – | Sell |
-409,881
| Closed | -$5.2M | – | 135 |
|
|
2015
Q2 | $5.2M | Sell |
409,881
-1,340,349
| -77% | -$17M | 0.05% | 78 |
|
|
2015
Q1 | $16.3M | Sell |
1,750,230
-2,721,923
| -61% | -$25.3M | 0.14% | 48 |
|
|
2014
Q4 | $64M | Buy |
4,472,153
+100,000
| +2% | +$1.43M | 0.65% | 23 |
|
|
2014
Q3 | $45.4M | Hold |
4,372,153
| – | – | 0.57% | 22 |
|
|
2014
Q2 | $70.7M | Sell |
4,372,153
-73,543
| -2% | -$1.19M | 0.87% | 18 |
|
|
2014
Q1 | $72.2M | Sell |
4,445,696
-345,483
| -7% | -$5.61M | 0.92% | 19 |
|
|
2013
Q4 | $59.5M | Hold |
4,791,179
| – | – | 0.84% | 17 |
|
|
2013
Q3 | $52.5M | Buy |
4,791,179
+825,000
| +21% | +$9.03M | 0.75% | 22 |
|
|
2013
Q2 | $32M | Buy |
+3,966,179
| New | +$32M | 0.63% | 23 |
|